S R McCann
Overview
Explore the profile of S R McCann including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
133
Citations
572
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Hennessy B, Dowd N, Crotty G, ORiordan J, White M, McCann S
Hematology
. 2016 Jul;
3(4):315-9.
PMID: 27413884
Recipients of allogeneic bone marrow transplantation frequently develop life threatening complications, which require intensive care management. The reported prognosis of bone marrow transplant (BMT) recipients who require admission to the...
3.
Urton J, McCann S, Peichel C
Cytogenet Genome Res
. 2011 Sep;
135(2):150-9.
PMID: 21921583
The stickleback family (Gasterosteidae) of fish is less than 40 million years old, yet stickleback species have diverged in both diploid chromosome number (2n) and morphology. We used comparative fluorescence...
4.
Lawler M, McCann S
Methods Mol Med
. 2011 Mar;
6:105-20.
PMID: 21380701
It is important to be able to assess the contribution of donor cells to the graft followmg bone marrow transplantation (BMT), as complete engraftment of marrow progenitors that can give...
5.
Hayat A, McGuckin S, Conneally E, Brown P, McCann S, Lawler M, et al.
Ir J Med Sci
. 2009 Jun;
178(4):441-6.
PMID: 19495836
Background: Combined Fludarabine and Cyclophosphamide is now standard first-line therapy in chronic lymphocytic leukaemia (CLL) and the addition of Rituximab improves outcome. Methods: We adopted a modified Fludarabine, Cyclophosphamide and...
6.
OConnor L, Langabeer S, McCann S, Conneally E
Bone Marrow Transplant
. 2008 Aug;
42(12):833-5.
PMID: 18711344
No abstract available.
7.
Forte L, Gardiner N, OConnell B, McCann S
Bone Marrow Transplant
. 2007 Jun;
40(4):389-90.
PMID: 17572717
No abstract available.
8.
ODonghaile D, Hayden P, McCarron S, Doyle E, Lawler M, Browne P, et al.
Eur J Haematol
. 2006 Feb;
76(3):258-60.
PMID: 16451399
Secondary or late graft failure has been defined as the development of inadequate marrow function after initial engraftment has been achieved. We describe a case of profound marrow aplasia occurring...
9.
Boublikova L, Kalinova M, Ryan J, Quinn F, OMarcaigh A, Smith O, et al.
Leukemia
. 2005 Dec;
20(2):254-63.
PMID: 16341043
Wilms' tumor gene 1 (WT1) is overexpressed in the majority (70-90%) of acute leukemias and has been identified as an independent adverse prognostic factor, a convenient minimal residual disease (MRD)...
10.
Hayden P, ODriscoll A, Gardiner N, Swords R, Sargent J, Ni Ainle F, et al.
Ir J Med Sci
. 2005 Aug;
174(2):26-32.
PMID: 16094909
Background: High-dose treatment with autologous stem cell transplantation (ASCT) has become the standard of care for patients with myeloma below the age of 65 years. Aims: We report an audit...